Drug & Device Regulation
In the U.S. the Food and Drug Administration (FDA) is the agency within the Department of Health and Human Services that is tasked with protecting public health by ensuring the safety and effectiveness of commercialized products, including pharmaceuticals, medical devices, veterinary medicines, and cosmetics. Regulatory professionals at clinical and translational research institutions and beyond help ensure the safety of FDA regulated products that are tested within their organization.
The course below provides an overview of how the FDA regulates drugs and medical devices that are tested using clinical trials.
Resources
Resources and literature related to regulation of medical products
Resources:
Resources:
- Duke Office of Regulatory Affairs and Quality
- Duke Regulatory Affairs Training Program
- Regulatory Affairs Professionals Society
- North Carolina Regulatory Affairs Forum (NCRAF)
- ReGARDD: Regulatory Guidance for Academic Research of Drugs and Devices
- The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH)
- FDA - Drugs | Biologics | Devices
- FDA Training and Continuing Education
- 21 CFR 312 - Investigational New Drug (IND) Regulations
- 21 CFR 812 - Investigational Device Exemption (IDE) Regulations
- Food, Drug, and Cosmetic Act
- 21st Century Cures Act
Terms and definitions related to regulation of medical products
Drug: an article that is intended:
Medical Device: an instrument, apparatus, implement, machine, contrivance, implant, in-vitro reagent or other similar or related article or component, part, or accessory which:
Investigational Device Exemption (IDE): a regulatory submission to the FDA that permits a significant-risk clinical investigation of a device.
Investigational New Drug (IND): a regulatory submission to the FDA that permits the clinical investigation of a drug.
Drug: an article that is intended:
- for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease OR
- to affect the structure or any function of the body
Medical Device: an instrument, apparatus, implement, machine, contrivance, implant, in-vitro reagent or other similar or related article or component, part, or accessory which:
- Is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease OR
- Is intended to affect the structure or any function of the body; AND
- Does not achieve any of its primary intended purposes through chemical action within or on the body and is not dependent upon being metabolized for the achievement of any of its primary intended purposes.
Investigational Device Exemption (IDE): a regulatory submission to the FDA that permits a significant-risk clinical investigation of a device.
Investigational New Drug (IND): a regulatory submission to the FDA that permits the clinical investigation of a drug.
Interview
Kristen Foss, Ph.D.
Senior Regulatory Affairs Scientist
Duke Office of Regulatory Affairs and Quality